This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Keio University, Kringle Pharma Inc., Osaka University. Active years: 2013.
Company Filing History:
1 out of 360 
1 out of 14 
1 out of 1,039 
Years Active: 2013
Title: Akio Iwanami: Innovator in Spinal Cord Injury Treatment
Introduction
Akio Iwanami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of spinal cord injuries. His innovative approach has the potential to change the lives of many individuals suffering from such conditions.
Latest Patents
Iwanami holds a patent for a therapeutic agent aimed at treating spinal cord injuries. This patent, which is focused on a fundamental treatment for spinal cord injuries and demyelinating diseases, discloses a therapeutic agent that comprises an HGF protein as an active ingredient. This breakthrough could pave the way for more effective treatments in the future.
Career Highlights
Throughout his career, Akio Iwanami has been associated with prestigious institutions such as Keio University and Osaka University. His work in these universities has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Iwanami has worked alongside notable colleagues, including Hideyuki Okano and Yoshiaki Toyama. Their combined expertise has fostered an environment of innovation and discovery in the realm of spinal cord injury treatment.
Conclusion
Akio Iwanami's contributions to the field of spinal cord injury treatment through his patent and collaborations highlight his role as a key innovator. His work continues to inspire advancements in medical science and offers hope for those affected by spinal cord injuries.